These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
90-0199783
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
100 Potrero Avenue
San Francisco, CA
|
94103-4813
|
(415) 558-0200
|
|
(Address of principal executive offices)
|
(Zip Code)
|
(Registrant’s telephone number, including area code)
|
|
Large accelerated filer
ý
|
|
Accelerated filer
¨
|
|
Non-accelerated filer
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
¨
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
||
|
Abbreviation
|
|
Term
|
|
AAC
|
|
Advanced Audio Coding
|
|
AOCI
|
|
Accumulated Other Comprehensive Income
|
|
APIC
|
|
Additional-Paid In-Capital
|
|
ASP
|
|
Average Selling Price
|
|
ASU
|
|
Accounting Standards Update
|
|
ATSC
|
|
Advanced Television Systems Committee
|
|
AVR
|
|
Audio/Video Receiver
|
|
CODM
|
|
Chief Operating Decision-Maker
|
|
COSO
|
|
Committee Of Sponsoring Organizations (Of The Treadway Commission)
|
|
DCI
|
|
Digital Cinema Initiative
|
|
DMA
|
|
Digital Media Adapter
|
|
DTV
|
|
Digital Television
|
|
DVD
|
|
Digital Versatile Disc
|
|
EPS
|
|
Earnings Per Share
|
|
ESP
|
|
Estimated Selling Price
|
|
ESPP
|
|
Employee Stock Purchase Plan
|
|
FASB
|
|
Financial Accounting Standards Board
|
|
FCPA
|
|
Foreign Corrupt Practices Act
|
|
G&A
|
|
General & Administrative
|
|
GAAP
|
|
Generally Accepted Accounting Principles
|
|
HDR
|
|
High Dynamic Range
|
|
HDTV
|
|
High Definition Television
|
|
HE AAC
|
|
High Efficiency Advanced Audio Coding
|
|
HEVC
|
|
High Efficiency Video Coding
|
|
HFR
|
|
High Frame Rate
|
|
HTIB
|
|
Home Theatre In-A-Box
|
|
IC
|
|
Integrated Circuit
|
|
IMB
|
|
Integrated Media Block
|
|
IPTV
|
|
Internet Protocol Television
|
|
ISO
|
|
Incentive Stock Option
|
|
ISV
|
|
Independent Software Vendor
|
|
IT
|
|
Information Technology
|
|
LCD
|
|
Liquid Crystal Display
|
|
ME
|
|
Multiple Element
|
|
NATO
|
|
North American Theatre Owners
|
|
NOL
|
|
Net Operating Loss
|
|
NQ
|
|
Non-Qualified/Non-Statutory Stock Option
|
|
OCI
|
|
Other Comprehensive Income
|
|
OECD
|
|
Organization For Economic Co-Operation & Development
|
|
OEM
|
|
Original Equipment Manufacturer
|
|
OTT
|
|
Over-The-Top
|
|
PC
|
|
Personal Computer
|
|
PCS
|
|
Post-Contract Support
|
|
PP&E
|
|
Property, Plant And Equipment
|
|
R&D
|
|
Research & Development
|
|
RSU
|
|
Restricted Stock Unit
|
|
S&M
|
|
Sales & Marketing
|
|
SAR
|
|
Stock Appreciation Rights
|
|
SERP
|
|
Supplemental Executive Retirement Plan
|
|
STB
|
|
Set-Top Box
|
|
TAM
|
|
Total Available Market
|
|
TPE
|
|
Third Party Evidence
|
|
UHD
|
|
Ultra High Definition
|
|
U.S. GAAP
|
|
Generally Accepted Accounting Principles In The United States
|
|
VSOE
|
|
Vendor Specific Objective Evidence
|
|
|
June 26,
2015 |
September 26,
2014 |
||||
|
ASSETS
|
(unaudited)
|
|
||||
|
Current assets:
|
|
|
||||
|
Cash and cash equivalents
|
$
|
470,868
|
|
$
|
568,472
|
|
|
Restricted cash
|
1,919
|
|
2,142
|
|
||
|
Short-term investments
|
165,833
|
|
231,208
|
|
||
|
Accounts receivable, net of allowance for doubtful accounts of $1,603 and $1,615
|
103,921
|
|
86,168
|
|
||
|
Inventories
|
20,070
|
|
8,536
|
|
||
|
Deferred taxes
|
87,367
|
|
86,445
|
|
||
|
Prepaid expenses and other current assets
|
45,551
|
|
22,880
|
|
||
|
Total current assets
|
895,529
|
|
1,005,851
|
|
||
|
Long-term investments
|
373,498
|
|
296,335
|
|
||
|
Property, plant and equipment, net
|
386,448
|
|
289,755
|
|
||
|
Intangible assets, net
|
117,726
|
|
63,700
|
|
||
|
Goodwill
|
312,454
|
|
277,574
|
|
||
|
Deferred taxes
|
56,217
|
|
41,746
|
|
||
|
Other non-current assets
|
9,763
|
|
9,051
|
|
||
|
Total assets
|
$
|
2,151,635
|
|
$
|
1,984,012
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
||||
|
Current liabilities:
|
|
|
||||
|
Accounts payable
|
$
|
27,566
|
|
$
|
15,898
|
|
|
Accrued liabilities
|
163,776
|
|
158,376
|
|
||
|
Income taxes payable
|
—
|
|
2,600
|
|
||
|
Deferred revenue
|
18,016
|
|
12,496
|
|
||
|
Total current liabilities
|
209,358
|
|
189,370
|
|
||
|
Long-term deferred revenue
|
29,661
|
|
19,279
|
|
||
|
Other non-current liabilities
|
72,633
|
|
43,715
|
|
||
|
Total liabilities
|
311,652
|
|
252,364
|
|
||
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
||||
|
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 51,903,757 shares issued and outstanding at June 26, 2015 and 50,658,627 at September 26, 2014
|
53
|
|
51
|
|
||
|
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 50,743,661 shares issued and outstanding at June 26, 2015 and 51,610,239 at September 26, 2014
|
51
|
|
52
|
|
||
|
Additional paid-in capital
|
65,586
|
|
46,415
|
|
||
|
Retained earnings
|
1,764,578
|
|
1,660,485
|
|
||
|
Accumulated other comprehensive income/(loss)
|
(7,391
|
)
|
3,014
|
|
||
|
Total stockholders’ equity – Dolby Laboratories, Inc.
|
1,822,877
|
|
1,710,017
|
|
||
|
Controlling interest
|
17,106
|
|
21,631
|
|
||
|
Total stockholders’ equity
|
1,839,983
|
|
1,731,648
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
2,151,635
|
|
$
|
1,984,012
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||||||
|
Revenue:
|
|
|
|
|
|
||||||||
|
Licensing
|
$
|
204,855
|
|
$
|
205,625
|
|
|
$
|
664,786
|
|
$
|
669,901
|
|
|
Products
|
22,596
|
|
12,971
|
|
|
58,844
|
|
45,638
|
|
||||
|
Services
|
4,251
|
|
4,754
|
|
|
14,260
|
|
17,680
|
|
||||
|
Total revenue
|
231,702
|
|
223,350
|
|
|
737,890
|
|
733,219
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Cost of revenue:
|
|
|
|
|
|
||||||||
|
Cost of licensing
|
1,347
|
|
4,389
|
|
|
8,615
|
|
12,132
|
|
||||
|
Cost of products
|
20,027
|
|
10,860
|
|
|
50,848
|
|
34,941
|
|
||||
|
Cost of services
|
3,506
|
|
3,620
|
|
|
9,976
|
|
10,683
|
|
||||
|
Total cost of revenue
|
24,880
|
|
18,869
|
|
|
69,439
|
|
57,756
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Gross margin
|
206,822
|
|
204,481
|
|
|
668,451
|
|
675,463
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating expenses:
|
|
|
|
|
|
||||||||
|
Research and development
|
45,508
|
|
46,786
|
|
|
150,703
|
|
136,047
|
|
||||
|
Sales and marketing
|
70,782
|
|
63,602
|
|
|
204,740
|
|
188,809
|
|
||||
|
General and administrative
|
45,587
|
|
44,205
|
|
|
135,956
|
|
132,570
|
|
||||
|
Restructuring charges/(credits)
|
—
|
|
(688
|
)
|
|
(39
|
)
|
2,613
|
|
||||
|
Total operating expenses
|
161,877
|
|
153,905
|
|
|
491,360
|
|
460,039
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Operating income
|
44,945
|
|
50,576
|
|
|
177,091
|
|
215,424
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Other income/expense:
|
|
|
|
|
|
||||||||
|
Interest income
|
1,453
|
|
959
|
|
|
3,444
|
|
2,533
|
|
||||
|
Interest expense
|
(69
|
)
|
(251
|
)
|
|
(115
|
)
|
(456
|
)
|
||||
|
Other income/(expense), net
|
1,049
|
|
530
|
|
|
1,159
|
|
(2,064
|
)
|
||||
|
Total other income
|
2,433
|
|
1,238
|
|
|
4,488
|
|
13
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Income before income taxes
|
47,378
|
|
51,814
|
|
|
181,579
|
|
215,437
|
|
||||
|
Provision for income taxes
|
(11,522
|
)
|
(11,251
|
)
|
|
(45,254
|
)
|
(53,079
|
)
|
||||
|
Net income including controlling interest
|
35,856
|
|
40,563
|
|
|
136,325
|
|
162,358
|
|
||||
|
Less: net (income) attributable to controlling interest
|
(350
|
)
|
(784
|
)
|
|
(1,488
|
)
|
(2,196
|
)
|
||||
|
Net income attributable to Dolby Laboratories, Inc.
|
$
|
35,506
|
|
$
|
39,779
|
|
|
$
|
134,837
|
|
$
|
160,162
|
|
|
|
|
|
|
|
|
||||||||
|
Net Income Per Share:
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.35
|
|
$
|
0.39
|
|
|
$
|
1.32
|
|
$
|
1.57
|
|
|
Diluted
|
$
|
0.34
|
|
$
|
0.38
|
|
|
$
|
1.29
|
|
$
|
1.55
|
|
|
Weighted-Average Shares Outstanding:
|
|
|
|
|
|
||||||||
|
Basic
|
102,670
|
|
102,350
|
|
|
102,494
|
|
102,131
|
|
||||
|
Diluted
|
104,105
|
|
103,942
|
|
|
104,127
|
|
103,605
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Related party rent expense:
|
|
|
|
|
|
||||||||
|
Included in operating expenses
|
$
|
815
|
|
$
|
640
|
|
|
$
|
2,358
|
|
$
|
1,332
|
|
|
Included in net income attributable to controlling interest
|
$
|
1,159
|
|
$
|
1,164
|
|
|
$
|
3,463
|
|
$
|
3,669
|
|
|
|
|
|
|
|
|
||||||||
|
Cash dividend declared per common share
|
$
|
0.10
|
|
$
|
—
|
|
|
$
|
0.30
|
|
$
|
—
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||||||
|
Net income including controlling interest
|
$
|
35,856
|
|
$
|
40,563
|
|
|
$
|
136,325
|
|
$
|
162,358
|
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
||||||
|
Foreign currency translation adjustments, net of tax
|
1,146
|
|
(75
|
)
|
|
(10,726
|
)
|
846
|
|
||||
|
Unrealized gains/(losses) on available-for-sale securities, net of tax
|
(729
|
)
|
279
|
|
|
(64
|
)
|
456
|
|
||||
|
Comprehensive income
|
36,273
|
|
40,767
|
|
|
125,535
|
|
163,660
|
|
||||
|
Less: comprehensive (income) attributable to controlling interest
|
(626
|
)
|
(1,004
|
)
|
|
(1,103
|
)
|
(2,634
|
)
|
||||
|
Comprehensive income attributable to Dolby Laboratories, Inc.
|
$
|
35,647
|
|
$
|
39,763
|
|
|
$
|
124,432
|
|
$
|
161,026
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common Stock
|
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income/(Loss)
|
Total Dolby Laboratories, Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
|
Balance at September 26, 2014
|
$
|
103
|
|
$
|
46,415
|
|
$
|
1,660,485
|
|
$
|
3,014
|
|
$
|
1,710,017
|
|
$
|
21,631
|
|
$
|
1,731,648
|
|
|
Net income
|
—
|
|
—
|
|
134,837
|
|
—
|
|
134,837
|
|
1,488
|
|
136,325
|
|
|||||||
|
Currency translation adjustments, net of tax of $641
|
—
|
|
—
|
|
—
|
|
(10,341
|
)
|
(10,341
|
)
|
(385
|
)
|
(10,726
|
)
|
|||||||
|
Unrealized losses on investments, net of tax of $(165)
|
—
|
|
—
|
|
—
|
|
(64
|
)
|
(64
|
)
|
—
|
|
(64
|
)
|
|||||||
|
Distributions to controlling interest
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(5,628
|
)
|
(5,628
|
)
|
|||||||
|
Stock-based compensation expense
|
—
|
|
50,822
|
|
—
|
|
—
|
|
50,822
|
|
—
|
|
50,822
|
|
|||||||
|
Repurchase of common stock
|
(1
|
)
|
(47,955
|
)
|
—
|
|
—
|
|
(47,956
|
)
|
—
|
|
(47,956
|
)
|
|||||||
|
Cash dividends declared and paid on common stock
|
—
|
|
—
|
|
(30,744
|
)
|
—
|
|
(30,744
|
)
|
—
|
|
(30,744
|
)
|
|||||||
|
Tax benefit from employee stock plans
|
—
|
|
1,167
|
|
—
|
|
—
|
|
1,167
|
|
—
|
|
1,167
|
|
|||||||
|
Common stock issued under employee stock plans
|
2
|
|
28,048
|
|
—
|
|
—
|
|
28,050
|
|
—
|
|
28,050
|
|
|||||||
|
Tax withholdings on vesting of restricted stock
|
—
|
|
(12,918
|
)
|
—
|
|
—
|
|
(12,918
|
)
|
—
|
|
(12,918
|
)
|
|||||||
|
Exercise of class B stock options
|
—
|
|
7
|
|
—
|
|
—
|
|
7
|
|
—
|
|
7
|
|
|||||||
|
Balance at June 26, 2015
|
$
|
104
|
|
$
|
65,586
|
|
$
|
1,764,578
|
|
$
|
(7,391
|
)
|
$
|
1,822,877
|
|
$
|
17,106
|
|
$
|
1,839,983
|
|
|
|
Dolby Laboratories, Inc.
|
|
|
||||||||||||||||||
|
|
Common Stock
|
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income
|
Total Dolby
Laboratories,
Inc.
|
Controlling
Interest
|
Total
|
||||||||||||||
|
Balance at September 27, 2013
|
$
|
102
|
|
$
|
18,812
|
|
$
|
1,454,382
|
|
$
|
7,814
|
|
$
|
1,481,110
|
|
$
|
18,916
|
|
$
|
1,500,026
|
|
|
Net income
|
—
|
|
—
|
|
160,162
|
|
—
|
|
160,162
|
|
2,196
|
|
162,358
|
|
|||||||
|
Currency translation adjustments, net of tax of $7
|
—
|
|
—
|
|
—
|
|
408
|
|
408
|
|
438
|
|
846
|
|
|||||||
|
Unrealized gains on investments, net of tax of $(254)
|
—
|
|
—
|
|
—
|
|
456
|
|
456
|
|
—
|
|
456
|
|
|||||||
|
Stock-based compensation expense
|
—
|
|
48,773
|
|
—
|
|
—
|
|
48,773
|
|
—
|
|
48,773
|
|
|||||||
|
Repurchase of common stock
|
(1
|
)
|
(40,957
|
)
|
—
|
|
—
|
|
(40,958
|
)
|
—
|
|
(40,958
|
)
|
|||||||
|
Tax (deficiency) from employee stock plans
|
—
|
|
(263
|
)
|
—
|
|
—
|
|
(263
|
)
|
—
|
|
(263
|
)
|
|||||||
|
Common stock issued under employee stock plans
|
2
|
|
23,856
|
|
—
|
|
—
|
|
23,858
|
|
—
|
|
23,858
|
|
|||||||
|
Tax withholdings on vesting of restricted stock
|
—
|
|
(9,221
|
)
|
—
|
|
—
|
|
(9,221
|
)
|
—
|
|
(9,221
|
)
|
|||||||
|
Exercise of class B stock options
|
—
|
|
289
|
|
—
|
|
—
|
|
289
|
|
—
|
|
289
|
|
|||||||
|
Balance at June 27, 2014
|
$
|
103
|
|
$
|
41,289
|
|
$
|
1,614,544
|
|
$
|
8,678
|
|
$
|
1,664,614
|
|
$
|
21,550
|
|
$
|
1,686,164
|
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
June 26,
2015 |
June 27,
2014 |
||||
|
Operating activities:
|
|
|
||||
|
Net income including controlling interest
|
$
|
136,325
|
|
$
|
162,358
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
||||
|
Depreciation and amortization
|
50,767
|
|
38,991
|
|
||
|
Stock-based compensation
|
50,822
|
|
48,773
|
|
||
|
Amortization of premium on investments
|
7,224
|
|
7,056
|
|
||
|
Excess tax benefit from exercise of stock options
|
(2,532
|
)
|
(1,857
|
)
|
||
|
Provision for doubtful accounts
|
(30
|
)
|
625
|
|
||
|
Deferred income taxes
|
(15,088
|
)
|
(9,936
|
)
|
||
|
Other non-cash items affecting net income
|
1,928
|
|
2,455
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
||||
|
Accounts receivable
|
(9,317
|
)
|
1,581
|
|
||
|
Inventories
|
5,238
|
|
2,654
|
|
||
|
Prepaid expenses and other assets
|
(6,179
|
)
|
(1,801
|
)
|
||
|
Accounts payable and other liabilities
|
(18,909
|
)
|
17,033
|
|
||
|
Income taxes, net
|
18,290
|
|
11,830
|
|
||
|
Deferred revenue
|
7,158
|
|
(7,956
|
)
|
||
|
Other non-current liabilities
|
420
|
|
162
|
|
||
|
Net cash provided by operating activities
|
226,117
|
|
271,968
|
|
||
|
|
|
|
||||
|
Investing activities:
|
|
|
||||
|
Purchase of investments
|
(357,096
|
)
|
(303,350
|
)
|
||
|
Proceeds from sales of investment securities
|
220,636
|
|
140,297
|
|
||
|
Proceeds from maturities of investment securities
|
117,545
|
|
105,602
|
|
||
|
Purchases of property, plant and equipment
|
(119,787
|
)
|
(37,122
|
)
|
||
|
Payments for business acquisitions, net of cash acquired
|
(93,516
|
)
|
—
|
|
||
|
Purchase of intangible assets
|
(22,716
|
)
|
(19,950
|
)
|
||
|
Proceeds from sale of property, plant and equipment and assets held for sale
|
18
|
|
3,355
|
|
||
|
Change in restricted cash
|
223
|
|
(159
|
)
|
||
|
Net cash used in investing activities
|
(254,693
|
)
|
(111,327
|
)
|
||
|
|
|
|
||||
|
Financing activities:
|
|
|
||||
|
Proceeds from issuance of common stock
|
28,057
|
|
24,147
|
|
||
|
Repurchase of common stock
|
(47,956
|
)
|
(40,958
|
)
|
||
|
Payment of cash dividend
|
(30,744
|
)
|
—
|
|
||
|
Distribution to controlling interest
|
(5,628
|
)
|
—
|
|
||
|
Excess tax benefit from the exercise of stock options
|
2,532
|
|
1,857
|
|
||
|
Shares repurchased for tax withholdings on vesting of restricted stock
|
(12,918
|
)
|
(9,221
|
)
|
||
|
Net cash used in financing activities
|
(66,657
|
)
|
(24,175
|
)
|
||
|
|
|
|
||||
|
Effect of foreign exchange rate changes on cash and cash equivalents
|
(2,371
|
)
|
(766
|
)
|
||
|
Net increase/(decrease) in cash and cash equivalents
|
(97,604
|
)
|
135,700
|
|
||
|
Cash and cash equivalents at beginning of period
|
568,472
|
|
454,397
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
470,868
|
|
$
|
590,097
|
|
|
|
|
|
||||
|
Supplemental disclosure:
|
|
|
||||
|
Cash paid for income taxes, net of refunds received
|
$
|
39,509
|
|
$
|
50,194
|
|
|
|
|
|
||||
|
Non-cash investing and financing activities:
|
|
|
||||
|
Change in property, plant and equipment purchased and unpaid at period-end
|
$
|
29,839
|
|
$
|
2,500
|
|
|
Purchase consideration payable for acquisition
|
$
|
740
|
|
$
|
—
|
|
|
Accounts Receivable, Net
|
June 26,
2015 |
September 26,
2014 |
||||
|
Trade accounts receivable
|
$
|
97,644
|
|
$
|
78,189
|
|
|
Accounts receivable from patent administration program customers
|
7,880
|
|
9,594
|
|
||
|
Accounts receivable, gross
|
105,524
|
|
87,783
|
|
||
|
Less: allowance for doubtful accounts
|
(1,603
|
)
|
(1,615
|
)
|
||
|
Total
|
$
|
103,921
|
|
$
|
86,168
|
|
|
Inventories
|
June 26,
2015 |
September 26,
2014 |
||||
|
Raw materials
|
$
|
7,152
|
|
$
|
1,013
|
|
|
Work in process
|
3,776
|
|
47
|
|
||
|
Finished goods
|
9,142
|
|
7,476
|
|
||
|
Total
|
$
|
20,070
|
|
$
|
8,536
|
|
|
Prepaid Expenses And Other Current Assets
|
June 26,
2015 |
September 26,
2014 |
||||
|
Prepaid expenses
|
$
|
15,410
|
|
$
|
11,665
|
|
|
Other current assets
|
19,043
|
|
7,152
|
|
||
|
Income tax receivable
|
11,098
|
|
4,063
|
|
||
|
Total
|
$
|
45,551
|
|
$
|
22,880
|
|
|
Accrued Liabilities
|
June 26,
2015 |
September 26,
2014 |
||||
|
Accrued royalties
|
$
|
1,965
|
|
$
|
2,526
|
|
|
Amounts payable to patent administration program partners
|
43,564
|
|
43,438
|
|
||
|
Accrued compensation and benefits
|
61,353
|
|
71,677
|
|
||
|
Accrued professional fees
|
4,195
|
|
6,162
|
|
||
|
Other accrued liabilities
|
52,699
|
|
34,573
|
|
||
|
Total
|
$
|
163,776
|
|
$
|
158,376
|
|
|
Other Non-Current Liabilities
|
June 26,
2015 |
September 26,
2014 |
||||
|
Supplemental retirement plan obligations
|
$
|
2,515
|
|
$
|
2,409
|
|
|
Non-current tax liabilities
|
57,513
|
|
30,715
|
|
||
|
Other liabilities
|
12,605
|
|
10,591
|
|
||
|
Total
|
$
|
72,633
|
|
$
|
43,715
|
|
|
|
June 26,
2015 |
|||||||||||||||||||||
|
|
Cost
|
Unrealized
|
|
|
Estimated Fair Value
|
|||||||||||||||||
|
|
Gains
|
Losses
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Cash
|
$
|
453,796
|
|
|
|
$
|
453,796
|
|
|
|
|
|
||||||||||
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Money market funds
|
16,117
|
|
|
|
16,117
|
|
|
16,117
|
|
|
|
|||||||||||
|
Municipal debt securities
|
955
|
|
|
|
955
|
|
|
|
955
|
|
|
|||||||||||
|
Cash and cash equivalents
|
470,868
|
|
—
|
|
—
|
|
470,868
|
|
|
16,117
|
|
955
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Government bonds
|
2,000
|
|
4
|
|
|
|
2,004
|
|
|
2,004
|
|
|
|
|||||||||
|
Commercial paper
|
6,469
|
|
4
|
|
|
|
6,473
|
|
|
|
6,473
|
|
|
|||||||||
|
Corporate bonds
|
81,115
|
|
49
|
|
(31
|
)
|
81,133
|
|
|
|
81,133
|
|
|
|||||||||
|
Municipal debt securities
|
76,116
|
|
107
|
|
|
|
76,223
|
|
|
|
76,223
|
|
|
|||||||||
|
Short-term investments
|
165,700
|
|
164
|
|
(31
|
)
|
165,833
|
|
|
2,004
|
|
163,829
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
U.S. agency securities
|
2,999
|
|
1
|
|
(3
|
)
|
2,997
|
|
|
2,997
|
|
|
|
|||||||||
|
Government bonds
|
24,520
|
|
2
|
|
(57
|
)
|
24,465
|
|
|
24,465
|
|
|
|
|||||||||
|
Corporate bonds
|
184,947
|
|
105
|
|
(293
|
)
|
184,759
|
|
|
|
184,759
|
|
|
|||||||||
|
Municipal debt securities
|
159,786
|
|
84
|
|
(230
|
)
|
159,640
|
|
|
|
159,640
|
|
|
|||||||||
|
Other long-term investments
(1)
|
1,637
|
|
|
|
|
|
1,637
|
|
|
1,131
|
|
|
506
|
|
||||||||
|
Long-term investments
|
373,889
|
|
192
|
|
(583
|
)
|
373,498
|
|
|
28,593
|
|
344,399
|
|
506
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total cash, cash equivalents, and investments
|
$
|
1,010,457
|
|
$
|
356
|
|
$
|
(614
|
)
|
$
|
1,010,199
|
|
|
$
|
46,714
|
|
$
|
509,183
|
|
$
|
506
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Investments held in supplemental retirement plan:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Assets
|
2,613
|
|
|
|
2,613
|
|
|
2,613
|
|
|
|
|||||||||||
|
Included in prepaid expenses and other current assets & other non-current assets
|
|
|
|
|
|
|||||||||||||||||
|
Liabilities
|
2,613
|
|
|
|
2,613
|
|
|
2,613
|
|
|
|
|||||||||||
|
Included in accrued liabilities & other non-current liabilities
|
|
|
|
|
|
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Contingent consideration related to acquisition:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Liabilities
|
740
|
|
|
|
740
|
|
|
|
|
|
740
|
|
||||||||||
|
Included in accrued liabilities
|
|
|
|
|
|
|||||||||||||||||
|
(1)
|
Other long-term investments as of
June 26, 2015
include a marketable equity security of
$1.1 million
and cost method investments of
$0.5 million
.
|
|
|
September 26,
2014 |
|||||||||||||||||||||
|
|
Cost
|
Unrealized
|
|
|
Estimated Fair Value
|
|||||||||||||||||
|
|
Gains
|
Losses
|
Total
|
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||||
|
Cash and cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Cash
|
$
|
564,745
|
|
|
|
|
|
$
|
564,745
|
|
|
|
|
|
|
|
|
|||||
|
Cash equivalents:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Money market funds
|
1,727
|
|
|
|
|
|
1,727
|
|
|
1,727
|
|
|
|
|
|
|||||||
|
Commercial paper
|
2,000
|
|
|
|
|
|
2,000
|
|
|
|
|
2,000
|
|
|
|
|||||||
|
Cash and cash equivalents
|
568,472
|
|
—
|
|
—
|
|
568,472
|
|
|
1,727
|
|
2,000
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Short-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
U.S. agency securities
|
35,443
|
|
5
|
|
(3
|
)
|
35,445
|
|
|
35,445
|
|
|
|
|
|
|||||||
|
Commercial paper
|
21,788
|
|
|
|
|
|
21,788
|
|
|
|
|
21,788
|
|
|
|
|||||||
|
Corporate bonds
|
56,106
|
|
81
|
|
(10
|
)
|
56,177
|
|
|
|
|
56,177
|
|
|
|
|||||||
|
Municipal debt securities
|
117,606
|
|
197
|
|
(5
|
)
|
117,798
|
|
|
|
|
117,798
|
|
|
|
|||||||
|
Short-term investments
|
230,943
|
|
283
|
|
(18
|
)
|
231,208
|
|
|
35,445
|
|
195,763
|
|
—
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Long-term investments:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
U.S. agency securities
|
31,980
|
|
19
|
|
(6
|
)
|
31,993
|
|
|
31,993
|
|
|
|
|
|
|||||||
|
Corporate bonds
|
117,063
|
|
226
|
|
(80
|
)
|
117,209
|
|
|
|
|
117,209
|
|
|
|
|||||||
|
Municipal debt securities
|
146,337
|
|
326
|
|
(30
|
)
|
146,633
|
|
|
|
|
146,633
|
|
|
|
|||||||
|
Other long-term investments
(1)
|
500
|
|
|
|
|
|
500
|
|
|
|
|
|
|
500
|
|
|||||||
|
Long-term investments
|
295,880
|
|
571
|
|
(116
|
)
|
296,335
|
|
|
31,993
|
|
263,842
|
|
500
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Total cash, cash equivalents, and investments
|
$
|
1,095,295
|
|
$
|
854
|
|
$
|
(134
|
)
|
$
|
1,096,015
|
|
|
$
|
69,165
|
|
$
|
461,605
|
|
$
|
500
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Investments held in supplemental retirement plan:
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Assets
|
2,507
|
|
|
|
|
|
2,507
|
|
|
2,507
|
|
|
|
|
|
|||||||
|
Included in prepaid expenses and other current assets & other non-current assets
|
|
|
|
|
|
|||||||||||||||||
|
Liabilities
|
2,507
|
|
|
|
|
|
2,507
|
|
|
2,507
|
|
|
|
|
|
|||||||
|
Included in accrued liabilities & other non-current liabilities
|
|
|
|
|
|
|||||||||||||||||
|
(1)
|
Other long-term investments as of
September 26, 2014
include a cost method investment of
$0.5 million
.
|
|
|
June 26, 2015
|
|
September 26, 2014
|
||||||||||
|
Investment Type
|
Fair Value
|
Gross Unrealized Losses
(1)
|
|
Fair Value
|
Gross Unrealized Losses
(1)
|
||||||||
|
U.S. agency securities
|
$
|
2,997
|
|
$
|
(3
|
)
|
|
$
|
31,930
|
|
$
|
(9
|
)
|
|
Government bonds
|
22,467
|
|
(57
|
)
|
|
—
|
|
—
|
|
||||
|
Corporate bonds
|
157,435
|
|
(324
|
)
|
|
78,166
|
|
(90
|
)
|
||||
|
Municipal debt securities
|
106,249
|
|
(230
|
)
|
|
55,979
|
|
(35
|
)
|
||||
|
Total
|
$
|
289,148
|
|
$
|
(614
|
)
|
|
$
|
166,075
|
|
$
|
(134
|
)
|
|
(1)
|
Our available-for-sale securities in an unrealized loss position were in such position for less than twelve months as of both
June 26, 2015
and
September 26, 2014
.
|
|
|
June 26, 2015
|
|
September 26, 2014
|
||||||||||
|
Range of maturity
|
Amortized Cost
|
Fair Value
|
|
Amortized Cost
|
Fair Value
|
||||||||
|
Due within 1 year
|
$
|
177,544
|
|
$
|
177,678
|
|
|
$
|
232,944
|
|
$
|
233,208
|
|
|
Due in 1 to 2 years
|
207,747
|
|
207,682
|
|
|
179,177
|
|
179,536
|
|
||||
|
Due in 2 to 3 years
|
169,734
|
|
169,406
|
|
|
116,204
|
|
116,299
|
|
||||
|
Total
|
$
|
555,025
|
|
$
|
554,766
|
|
|
$
|
528,325
|
|
$
|
529,043
|
|
|
Property, Plant And Equipment
|
June 26,
2015 |
|
September 26,
2014 |
||||
|
Land
|
$
|
43,579
|
|
|
$
|
45,842
|
|
|
Buildings and building improvements
|
218,682
|
|
|
61,712
|
|
||
|
Leasehold improvements
|
60,431
|
|
|
56,665
|
|
||
|
Machinery and equipment
|
60,469
|
|
|
47,639
|
|
||
|
Computer systems and software
|
129,802
|
|
|
108,225
|
|
||
|
Furniture and fixtures
|
24,766
|
|
|
13,540
|
|
||
|
Construction-in-progress
|
52,572
|
|
|
127,569
|
|
||
|
Property, plant and equipment, gross
|
590,301
|
|
|
461,192
|
|
||
|
Less: accumulated depreciation
|
(203,853
|
)
|
|
(171,437
|
)
|
||
|
Property, plant and equipment, net
|
$
|
386,448
|
|
|
$
|
289,755
|
|
|
|
Goodwill
|
||
|
Balance at September 26, 2014
|
$
|
277,574
|
|
|
Acquired goodwill
(1)
|
40,372
|
|
|
|
Translation adjustments
|
(5,492
|
)
|
|
|
Balance at June 26, 2015
|
$
|
312,454
|
|
|
(1)
|
Total acquired goodwill recorded during fiscal
2015
consists of
$39.7 million
from the acquisition of Doremi Labs and
$0.7 million
from an immaterial acquisition.
|
|
|
June 26, 2015
|
|
September 26, 2014
|
||||||||||||||||
|
Intangible Assets, Net
|
Cost
|
Accumulated
Amortization
|
Net
|
|
Cost
|
Accumulated
Amortization
|
Net
|
||||||||||||
|
Acquired patents and technology
|
$
|
158,782
|
|
$
|
(71,465
|
)
|
$
|
87,317
|
|
|
$
|
99,262
|
|
$
|
(61,678
|
)
|
$
|
37,584
|
|
|
Customer relationships
|
56,934
|
|
(26,821
|
)
|
30,113
|
|
|
30,717
|
|
(22,739
|
)
|
7,978
|
|
||||||
|
Other intangibles
|
21,907
|
|
(21,611
|
)
|
296
|
|
|
38,694
|
|
(20,556
|
)
|
18,138
|
|
||||||
|
Total
|
$
|
237,623
|
|
$
|
(119,897
|
)
|
$
|
117,726
|
|
|
$
|
168,673
|
|
$
|
(104,973
|
)
|
$
|
63,700
|
|
|
Fiscal Year
|
Amortization Expense
|
||
|
Remainder Of 2015
|
$
|
4,900
|
|
|
2016
|
17,758
|
|
|
|
2017
|
14,894
|
|
|
|
2018
|
9,986
|
|
|
|
2019
|
9,716
|
|
|
|
Thereafter
|
60,472
|
|
|
|
Total
|
$
|
117,726
|
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
Weighted-Average
Remaining
Contractual Life
|
Aggregate
Intrinsic
Value
(1)
|
|||||
|
|
(in thousands)
|
|
(in years)
|
(in thousands)
|
|||||
|
Options outstanding at September 26, 2014
|
7,611
|
|
$
|
32.96
|
|
|
|
||
|
Grants
|
2,500
|
|
42.67
|
|
|
|
|||
|
Exercises
|
(695
|
)
|
28.12
|
|
|
|
|||
|
Forfeitures and cancellations
|
(511
|
)
|
36.41
|
|
|
|
|||
|
Options outstanding at June 26, 2015
|
8,905
|
|
35.86
|
|
7.5
|
$
|
52,352
|
|
|
|
Options vested and expected to vest at June 26, 2015
|
8,445
|
|
35.54
|
|
7.4
|
52,002
|
|
||
|
Options exercisable at June 26, 2015
|
4,167
|
|
$
|
32.21
|
|
6.1
|
38,236
|
|
|
|
(1)
|
Aggregate intrinsic value is based on the closing price of our common stock on
June 26, 2015
of
$40.34
and excludes the impact of options that were not in-the-money.
|
|
|
Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||
|
|
(in thousands)
|
|
|||
|
Non-vested at September 26, 2014
|
2,903
|
|
$
|
35.79
|
|
|
Granted
|
1,265
|
|
42.23
|
|
|
|
Vested
|
(890
|
)
|
36.75
|
|
|
|
Forfeitures
|
(211
|
)
|
31.62
|
|
|
|
Non-vested at June 26, 2015
|
3,067
|
|
$
|
38.45
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||
|
Expected term (in years)
|
5.21
|
|
4.58
|
|
|
4.79
|
|
4.58
|
|
|
Risk-free interest rate
|
1.5
|
%
|
1.5
|
%
|
|
1.5
|
%
|
1.4
|
%
|
|
Expected stock price volatility
|
29.0
|
%
|
31.5
|
%
|
|
29.7
|
%
|
32.0
|
%
|
|
Dividend yield
|
1.0
|
%
|
—
|
%
|
|
0.9
|
%
|
—
|
%
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||||||
|
Compensation Expense - By Type
|
|
|
|
|
|
||||||||
|
Stock options
|
$
|
5,501
|
|
$
|
5,121
|
|
|
$
|
17,513
|
|
$
|
14,378
|
|
|
Restricted stock units
|
10,005
|
|
9,899
|
|
|
30,297
|
|
31,721
|
|
||||
|
Employee stock purchase plan
|
807
|
|
946
|
|
|
3,012
|
|
2,674
|
|
||||
|
Total stock-based compensation
|
16,313
|
|
15,966
|
|
|
50,822
|
|
48,773
|
|
||||
|
Benefit from income taxes
|
(4,774
|
)
|
(4,700
|
)
|
|
(14,815
|
)
|
(14,386
|
)
|
||||
|
Total stock-based compensation, net of tax
|
$
|
11,539
|
|
$
|
11,266
|
|
|
$
|
36,007
|
|
$
|
34,387
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||||||
|
Compensation Expense - By Classification
|
|
|
|
|
|||||||||
|
Cost of products
|
$
|
241
|
|
$
|
193
|
|
|
$
|
711
|
|
$
|
600
|
|
|
Cost of services
|
111
|
|
97
|
|
|
348
|
|
297
|
|
||||
|
Research and development
|
4,261
|
|
4,476
|
|
|
14,473
|
|
13,672
|
|
||||
|
Sales and marketing
|
6,405
|
|
5,764
|
|
|
17,890
|
|
17,121
|
|
||||
|
General and administrative
|
5,295
|
|
5,436
|
|
|
17,400
|
|
17,083
|
|
||||
|
Total stock-based compensation
|
16,313
|
|
15,966
|
|
|
50,822
|
|
48,773
|
|
||||
|
Benefit from income taxes
|
(4,774
|
)
|
(4,700
|
)
|
|
(14,815
|
)
|
(14,386
|
)
|
||||
|
Total stock-based compensation, net of tax
|
$
|
11,539
|
|
$
|
11,266
|
|
|
$
|
36,007
|
|
$
|
34,387
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||||||
|
Tax benefit - stock option exercises & shares issued under ESPP
|
$
|
121
|
|
$
|
148
|
|
|
$
|
308
|
|
$
|
458
|
|
|
Authorization Period
|
Authorization Amount
|
||
|
Fiscal 2010: November 2009
|
$
|
250,000
|
|
|
Fiscal 2010: July 2010
|
300,000
|
|
|
|
Fiscal 2011: July 2011
|
250,000
|
|
|
|
Fiscal 2012: February 2012
|
100,000
|
|
|
|
Fiscal 2015: October 2014
|
200,000
|
|
|
|
Total
|
$
|
1,100,000
|
|
|
Quarterly Repurchase Activity
|
Shares
Repurchased
|
Cost
(1)
|
Average Price Paid Per Share
(2)
|
|||||
|
|
|
(in thousands)
|
|
|||||
|
Q1 - Quarter ended December 26, 2014
|
389,500
|
|
$
|
16,953
|
|
$
|
43.51
|
|
|
Q2 - Quarter ended March 27, 2015
|
390,000
|
|
15,411
|
|
39.47
|
|
||
|
Q3 - Quarter ended June 26, 2015
|
390,000
|
|
15,592
|
|
39.96
|
|
||
|
Total
|
1,169,500
|
|
$
|
47,956
|
|
|
||
|
(1)
|
Cost of share repurchases includes the price paid per share and applicable commissions.
|
|
(2)
|
Average price paid per share excludes commission costs.
|
|
Fiscal Period
|
Declaration Date
|
Record Date
|
Payment Date
|
Cash Dividend Per Common Share
|
Dividend Payment
|
||
|
Fiscal 2014
|
|
|
|
|
|
||
|
Q4 - Quarter ended September 26, 2014
|
October 21, 2014
|
November 3, 2014
|
November 20, 2014
|
$
|
0.10
|
|
$10.2 million
|
|
|
|
|
|
|
|
||
|
Fiscal 2015
|
|
|
|
|
|
||
|
Q1 - Quarter ended December 26, 2014
|
January 19, 2015
|
February 2, 2015
|
February 10, 2015
|
$
|
0.10
|
|
$10.3 million
|
|
Q2 - Quarter ended March 27, 2015
|
April 20, 2015
|
May 4, 2015
|
May 12, 2015
|
$
|
0.10
|
|
$10.3 million
|
|
Q3 - Quarter ended June 26, 2015
|
July 20, 2015
|
August 3, 2015
|
August 11, 2015
|
$
|
0.10
|
|
$10.3 million (1)
|
|
(1)
|
The amount of the dividend payment is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.
|
|
|
Fiscal Quarter Ended
June 26, 2015
|
|
Fiscal Year-To-Date Ended
June 26, 2015
|
||||||||||||||||
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
||||||||||||
|
Balance, beginning of period
|
$
|
1,170
|
|
$
|
(8,702
|
)
|
$
|
(7,532
|
)
|
|
$
|
505
|
|
$
|
2,509
|
|
$
|
3,014
|
|
|
Other comprehensive income before reclassifications:
|
|
|
|
|
|
|
|
||||||||||||
|
Unrealized gains/(losses) - investment securities
|
(787
|
)
|
|
|
(787
|
)
|
|
382
|
|
|
|
382
|
|
||||||
|
Foreign currency translation gains/(losses)
(1)
|
|
|
1,058
|
|
1,058
|
|
|
|
|
(10,982
|
)
|
(10,982
|
)
|
||||||
|
Income tax effect - benefit/(expense)
(2)
|
162
|
|
(188
|
)
|
(26
|
)
|
|
(165
|
)
|
641
|
|
476
|
|
||||||
|
Net of tax
|
(625
|
)
|
870
|
|
245
|
|
|
217
|
|
(10,341
|
)
|
(10,124
|
)
|
||||||
|
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Realized (gains) - investment securities
(1)
|
(138
|
)
|
|
|
(138
|
)
|
|
(342
|
)
|
|
|
(342
|
)
|
||||||
|
Income tax effect - expense
(2)
|
34
|
|
|
|
34
|
|
|
61
|
|
|
|
61
|
|
||||||
|
Net of tax
|
(104
|
)
|
—
|
|
(104
|
)
|
|
(281
|
)
|
—
|
|
(281
|
)
|
||||||
|
Net current-period other comprehensive income/(loss)
|
(729
|
)
|
870
|
|
141
|
|
|
(64
|
)
|
(10,341
|
)
|
(10,405
|
)
|
||||||
|
Balance, end of period
|
$
|
441
|
|
$
|
(7,832
|
)
|
$
|
(7,391
|
)
|
|
$
|
441
|
|
$
|
(7,832
|
)
|
$
|
(7,391
|
)
|
|
|
Fiscal Quarter Ended
June 27, 2014
|
|
Fiscal Year-To-Date Ended
June 27, 2014
|
||||||||||||||||
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
|
Investment Securities
|
Currency Translation Adjustments
|
Total
|
||||||||||||
|
Balance, beginning of period
|
$
|
380
|
|
$
|
8,314
|
|
$
|
8,694
|
|
|
$
|
203
|
|
$
|
7,611
|
|
$
|
7,814
|
|
|
Other comprehensive income before reclassifications:
|
|
|
|
|
|
|
|
||||||||||||
|
Unrealized gains - investment securities
|
484
|
|
|
484
|
|
|
1,055
|
|
|
1,055
|
|
||||||||
|
Foreign currency translation gains/(losses)
(1)
|
|
(366
|
)
|
(366
|
)
|
|
|
401
|
|
401
|
|
||||||||
|
Income tax effect - benefit/(expense)
(2)
|
(173
|
)
|
71
|
|
(102
|
)
|
|
(377
|
)
|
7
|
|
(370
|
)
|
||||||
|
Net of tax
|
311
|
|
(295
|
)
|
16
|
|
|
678
|
|
408
|
|
1,086
|
|
||||||
|
Amounts reclassified from AOCI into earnings:
|
|
|
|
|
|
|
|
||||||||||||
|
Realized (gains) - investment securities
(1)
|
(49
|
)
|
|
(49
|
)
|
|
(345
|
)
|
|
(345
|
)
|
||||||||
|
Income tax effect - expense
(2)
|
17
|
|
|
17
|
|
|
123
|
|
|
123
|
|
||||||||
|
Net of tax
|
(32
|
)
|
—
|
|
(32
|
)
|
|
(222
|
)
|
—
|
|
(222
|
)
|
||||||
|
Net current-period other comprehensive income/(loss)
|
279
|
|
(295
|
)
|
(16
|
)
|
|
456
|
|
408
|
|
864
|
|
||||||
|
Balance, end of period
|
$
|
659
|
|
$
|
8,019
|
|
$
|
8,678
|
|
|
$
|
659
|
|
$
|
8,019
|
|
$
|
8,678
|
|
|
(1)
|
Realized gains or losses from the sale of our available-for-sale investment securities or from foreign currency translation adjustments are included within other income/expense, net in our consolidated statements of operations.
|
|
(2)
|
The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||||||
|
Numerator:
|
|
|
|
|
|
||||||||
|
Net income attributable to Dolby Laboratories, Inc.
|
$
|
35,506
|
|
$
|
39,779
|
|
|
$
|
134,837
|
|
$
|
160,162
|
|
|
|
|
|
|
|
|
||||||||
|
Denominator:
|
|
|
|
|
|
||||||||
|
Weighted-average shares outstanding—basic
|
102,670
|
|
102,350
|
|
|
102,494
|
|
102,131
|
|
||||
|
Potential common shares from options to purchase common stock
|
827
|
|
616
|
|
|
903
|
|
500
|
|
||||
|
Potential common shares from restricted stock units
|
608
|
|
976
|
|
|
730
|
|
974
|
|
||||
|
Weighted-average shares outstanding—diluted
|
104,105
|
|
103,942
|
|
|
104,127
|
|
103,605
|
|
||||
|
|
|
|
|
|
|
||||||||
|
Net income per share attributable to Dolby Laboratories, Inc.:
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.35
|
|
$
|
0.39
|
|
|
$
|
1.32
|
|
$
|
1.57
|
|
|
Diluted
|
$
|
0.34
|
|
$
|
0.38
|
|
|
$
|
1.29
|
|
$
|
1.55
|
|
|
|
|
|
|
|
|
||||||||
|
Antidilutive awards excluded from calculation:
|
|
|
|
|
|
||||||||
|
Stock options
|
4,617
|
|
3,563
|
|
|
3,962
|
|
3,915
|
|
||||
|
Restricted stock units
|
10
|
|
184
|
|
|
6
|
|
1,756
|
|
||||
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||||||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
||||||||
|
Withholding taxes
|
$
|
10,021
|
|
$
|
12,022
|
|
|
$
|
34,163
|
|
$
|
35,120
|
|
|
|
Severance and associated costs
|
||
|
Balance at September 26, 2014
|
$
|
146
|
|
|
Restructuring (credits)
|
(39
|
)
|
|
|
Cash payments
|
(10
|
)
|
|
|
Non-cash and other adjustments
|
(97
|
)
|
|
|
Balance at June 26, 2015
|
$
|
—
|
|
|
|
Payments Due By Fiscal Period
|
||||||||||||||||||||
|
|
Remainder Of Fiscal 2015
|
Fiscal
2016 |
Fiscal
2017 |
Fiscal
2018 |
Fiscal
2019 |
Thereafter
|
Total
|
||||||||||||||
|
Naming rights
|
$
|
—
|
|
$
|
7,525
|
|
$
|
7,619
|
|
$
|
7,715
|
|
$
|
7,811
|
|
$
|
110,888
|
|
$
|
141,558
|
|
|
Donation commitments
|
—
|
|
—
|
|
6,045
|
|
67
|
|
67
|
|
805
|
|
6,984
|
|
|||||||
|
Operating leases
|
2,786
|
|
11,889
|
|
10,418
|
|
8,745
|
|
7,635
|
|
38,042
|
|
79,515
|
|
|||||||
|
Purchase obligations
|
1,032
|
|
1,683
|
|
62
|
|
—
|
|
—
|
|
—
|
|
2,777
|
|
|||||||
|
Total
|
$
|
3,818
|
|
$
|
21,097
|
|
$
|
24,144
|
|
$
|
16,527
|
|
$
|
15,513
|
|
$
|
149,735
|
|
$
|
230,834
|
|
|
Purchase Price Allocation
|
|
||
|
Current assets
|
$
|
17,231
|
|
|
Inventories
|
16,372
|
|
|
|
Intangible assets
|
45,600
|
|
|
|
Goodwill
|
39,672
|
|
|
|
Current liabilities
|
(11,653
|
)
|
|
|
Non-current liabilities
|
(8,820
|
)
|
|
|
Cash consideration paid to sellers
|
98,402
|
|
|
|
Add: contingent consideration
|
740
|
|
|
|
Total purchase consideration
|
$
|
99,142
|
|
|
Intangible Assets Acquired
|
Purchase Price Allocation
|
Weighted-Average Useful Life (Years)
|
Income Statement Classification: Amortization Expense
|
|
Customer relationships
|
$25,600
|
10
|
Sales & Marketing
|
|
Developed technology
|
17,500
|
7.5
|
Cost of Sales
|
|
Trade name
|
1,300
|
1
|
Sales & Marketing
|
|
Backlog
|
1,200
|
1
|
Cost of Sales
|
|
Total
|
$45,600
|
|
|
|
•
|
Customer relationships and backlog - Primarily the excess earnings method using inputs such as probability-weighted revenue attributable to existing customer relationships, customer attrition, estimated expenses, effective income tax rate, and discount rate.
|
|
•
|
Developed technology and Trade name - Primarily the relief-from-royalty method using inputs such as estimated revenues attributable to the digital cinema server technology, estimated net royalty rate, maintenance R&D expenses, effective income tax rate, and discount rate.
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
Revenue
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
|
Licensing
|
88%
|
92%
|
|
90%
|
92%
|
|
Products
|
10%
|
6%
|
|
8%
|
6%
|
|
Services
|
2%
|
2%
|
|
2%
|
2%
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
Fiscal Year-To-Date Ended
|
|
|
Revenue By Geographic Location
|
June 26,
2015 |
June 27,
2014 |
|
United States
|
29%
|
29%
|
|
International
|
71%
|
71%
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
|
||
|
Market
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
Main Products Incorporating Our Technologies
|
|
Broadcast
|
46%
|
43%
|
|
43%
|
42%
|
Televisions & STBs
|
|
PC
|
18%
|
19%
|
|
17%
|
19%
|
Windows operating systems & DVD software players
|
|
Consumer Electronics
|
11%
|
14%
|
|
14%
|
15%
|
DVD and Blu-ray Disc devices, AVRs, & HTIBs
|
|
Mobile
|
13%
|
13%
|
|
13%
|
13%
|
Smartphones, tablets & other mobile devices
|
|
Other
|
12%
|
11%
|
|
13%
|
11%
|
Video game consoles, automobile entertainment & audio conferencing
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
Market
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
|
Cinema
|
90%
|
87%
|
|
89%
|
86%
|
|
Broadcast
|
4%
|
11%
|
|
7%
|
10%
|
|
Other
|
6%
|
2%
|
|
4%
|
4%
|
|
Total
|
100%
|
100%
|
|
100%
|
100%
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
Licensing
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
Revenue
|
$204,855
|
$205,625
|
$(770)
|
—%
|
|
$664,786
|
$669,901
|
$(5,115)
|
(1)%
|
|
Percentage of total revenue
|
88%
|
92%
|
|
|
|
90%
|
92%
|
|
|
|
Cost of licensing
|
1,347
|
4,389
|
(3,042)
|
(69)%
|
|
8,615
|
12,132
|
(3,517)
|
(29)%
|
|
Gross margin
|
203,508
|
201,236
|
2,272
|
1%
|
|
656,171
|
657,769
|
(1,598)
|
—%
|
|
Gross margin percentage
|
99%
|
98%
|
|
|
|
99%
|
98%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Broadcast
|
á
|
Increase in backpayments and patent licensing, partially offset by a decrease in TV shipments that incorporate our technologies
|
ßà
|
Decreased primarily due to lower than expected royalty charges included in cost of licensing in the current quarter
|
|
CE
|
â
|
Lower net shipments of AVRs, DVD, Blu-ray, HTIBs, and other products that incorporate our technologies
|
||
|
PC
|
â
|
Lower ASPs resulting from product mix as fewer PCs included optical disc drives along with lower shipments, partially offset by an increase in back payments
|
||
|
Mobile
|
ßà
|
No significant fluctuations
|
||
|
Other
|
â
|
Lower revenues from Via Licensing patent pools and lower shipments of gaming consoles, offset by higher royalties from the automotive segment
|
||
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Other
|
á
|
Higher shipments of gaming consoles, higher automotive DVD shipments, and increased revenues from both Via Licensing patent pools and Dolby Voice
|
ßà
|
Decreased primarily due to lower than expected royalty charges included in cost of licensing in the current fiscal year to date
|
|
CE
|
â
|
Lower shipments of AVRs, DVD, Blu-ray, HTIB and other products that incorporate our technologies, partially offset by higher shipments of soundbars
|
||
|
PC
|
â
|
Lower ASPs from product mix as fewer PCs included optical disc drives along with lower shipments
|
||
|
Broadcast
|
á
|
Increase in patent licensing and from higher STB and TV shipments that incorporate our technologies, partially offset by a decrease in back payments received
|
||
|
Mobile
|
ßà
|
No significant fluctuations
|
||
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
Products
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
Revenue
|
$22,596
|
$12,971
|
$9,625
|
74%
|
|
$58,844
|
$45,638
|
$13,206
|
29%
|
|
Percentage of total revenue
|
10%
|
6%
|
|
|
|
8%
|
6%
|
|
|
|
Cost of products
|
20,027
|
10,860
|
9,167
|
84%
|
|
50,848
|
34,941
|
15,907
|
46%
|
|
Gross margin
|
2,569
|
2,111
|
458
|
22%
|
|
7,996
|
10,697
|
(2,701)
|
(25)%
|
|
Gross margin percentage
|
11%
|
16%
|
|
|
|
14%
|
23%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Cinema
|
á
|
Higher sales of digital server products from our acquisition of Doremi Labs in fiscal 2015
|
â
|
Higher charges from excess and obsolete digital video inventory and higher manufacturing costs
|
|
Other
|
No significant fluctuations
|
â
|
Higher amortization on newly-acquired intangible assets (refer to footnote 13 for additional information)
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Cinema
|
á
|
Higher sales of digital server products from our acquisition of Doremi Labs in fiscal 2015, partially offset by lower shipments and lower ASPs of mature Dolby cinema audio products
|
â
|
Lower ASPs of mature Dolby cinema audio products in addition to higher charges from excess and obsolete digital video inventory and higher manufacturing costs
|
|
Other
|
No significant fluctuations
|
â
|
Higher amortization on newly-acquired intangible assets (refer to footnote 13 for additional information)
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
Services
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
Revenue
|
$4,251
|
$4,754
|
$(503)
|
(11)%
|
|
$14,260
|
$17,680
|
$(3,420)
|
(19)%
|
|
Percentage of total revenue
|
2%
|
2%
|
|
|
|
2%
|
2%
|
|
|
|
Cost of services
|
3,506
|
3,620
|
(114)
|
(3)%
|
|
9,976
|
10,683
|
(707)
|
(7)%
|
|
Gross margin
|
745
|
1,134
|
(389)
|
(34)%
|
|
4,284
|
6,997
|
(2,713)
|
(39)%
|
|
Gross margin percentage
|
18%
|
24%
|
|
|
|
30%
|
40%
|
|
|
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Configuration & Post-Production
|
â
|
Lower film mastering and other services
|
â
|
Decrease correlates primarily to lower revenues
|
|
Support & Other
|
á
|
Higher support and maintenance services and warranties
|
||
|
Factor
|
Revenue
|
Gross Margin
|
||
|
Configuration & Post-Production
|
â
|
Lower film mastering and other services
|
â
|
The prior year-to-date comparative period includes the recognition of previously deferred revenue with no associated COGS
|
|
Support & Other
|
á
|
Increase in revenue from support and maintenance services and warranties
|
á
|
Lower labor and other related costs
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
Research and development
|
$45,508
|
$46,786
|
$(1,278)
|
(3)%
|
|
$150,703
|
$136,047
|
$14,656
|
11%
|
|
Percentage of total revenue
|
20%
|
21%
|
|
|
|
20%
|
19%
|
|
|
|
Category
|
Key Drivers
|
|
|
Technology & Communications
|
â
|
Benefit from a favorable resolution of a software license dispute
|
|
Compensation & Benefits
|
á
|
Higher employee headcount including personnel from the acquisition of Doremi Labs (refer to footnote 13 for additional information) and related expenses
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher employee headcount including personnel from the acquisition of Doremi Labs (refer to footnote 13 for additional information) and related expenses
|
|
Product Development
|
á
|
Higher costs related primarily to the funding of various research projects and initiatives aimed at developing new products and technologies
|
|
Depreciation & Amortization
|
á
|
Higher depreciation expense primarily from assets placed into service
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
Sales and marketing
|
$70,782
|
$63,602
|
$7,180
|
11%
|
|
$204,740
|
$188,809
|
$15,931
|
8%
|
|
Percentage of total revenue
|
31%
|
29%
|
|
|
|
28%
|
26%
|
|
|
|
Category
|
Key Drivers
|
|
|
Marketing Programs
|
á
|
Higher costs associated with industry trade shows and other marketing events
|
|
Depreciation & Amortization
|
á
|
Higher depreciation expense primarily from amortization on newly-acquired intangible assets (refer to footnote 13 for additional information) recorded and from assets placed into service
|
|
Compensation & Benefits
|
á
|
Higher employee headcount including personnel from the acquisition of Doremi Labs (refer to footnote 13 for additional information)
|
|
Category
|
Key Drivers
|
|
|
Compensation & Benefits
|
á
|
Higher employee headcount including personnel from the acquisition of Doremi Labs (refer to footnote 13 for additional information), and higher variable compensation costs
|
|
Depreciation & Amortization
|
á
|
Higher depreciation expense primarily from amortization on newly-acquired intangible assets (refer to footnote 13 for additional information) recorded and from assets placed into service
|
|
Marketing Programs
|
á
|
Higher costs associated with industry trade shows and other marketing events
|
|
Legal, Professional & Consulting Fees
|
â
|
Lower consulting and other costs relative to the prior comparative period, partially offset by higher professional fees for intellectual property related activities
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
General and administrative
|
$45,587
|
$44,205
|
$1,382
|
3%
|
|
$135,956
|
$132,570
|
$3,386
|
3%
|
|
Percentage of total revenue
|
20%
|
20%
|
|
|
|
18%
|
18%
|
|
|
|
Category
|
Key Drivers
|
|
|
Depreciation & Amortization
|
á
|
Higher depreciation expense primarily from assets placed into service including the partial occupation of our new worldwide headquarters
|
|
Compensation & Benefits
|
á
|
Higher employee headcount
|
|
Legal, Professional & Consulting Fees
|
â
|
Lower costs incurred in connection with our acquisition of Doremi Labs relative to the prior comparative period along with a decrease in costs associated with patent filings and other legal activities
|
|
Category
|
Key Drivers
|
|
|
Legal, Professional & Consulting Fees
|
â
|
Lower costs incurred in connection with our acquisition of Doremi Labs relative to the prior comparative period along with a decrease in costs associated with patent filings and other legal activities
|
|
Depreciation & Amortization
|
á
|
Higher depreciation expense primarily from assets placed into service including the partial occupation of our new worldwide headquarters
|
|
Compensation & Benefits
|
á
|
Higher employee headcount
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
Restructuring
|
$—
|
$(688)
|
$688
|
(100)%
|
|
$(39)
|
$2,613
|
$(2,652)
|
(101)%
|
|
Percentage of total revenue
|
—%
|
—%
|
|
|
|
—%
|
—%
|
|
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||||||
|
Other Income/Expense
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
June 26,
2015 |
June 27,
2014 |
$
|
%
|
|
Interest income
|
$1,453
|
$959
|
$494
|
52%
|
|
$3,444
|
$2,533
|
$911
|
36%
|
|
Interest expense
|
(69)
|
(251)
|
182
|
(73)%
|
|
(115)
|
(456)
|
341
|
(75)%
|
|
Other income/(expense), net
|
1,049
|
530
|
519
|
98%
|
|
1,159
|
(2,064)
|
3,223
|
(156)%
|
|
Total
|
$2,433
|
$1,238
|
$1,195
|
97%
|
|
$4,488
|
$13
|
$4,475
|
34,423%
|
|
Category
|
Key Drivers
|
|
|
Interest Income
|
á
|
Increase due to higher overall investment balances and higher yields during the current fiscal period relative to the prior comparative period
|
|
Other Income/Expense
|
á
|
Increase in other income due to amounts related to a governmental grant, partially offset by increase in other expense due to higher net losses attributed to foreign exchange rate fluctuations
|
|
Category
|
Key Drivers
|
|
|
Other Expense
|
á
|
Decrease in other expense as the prior fiscal comparative period included a $3M impairment charge recorded on a cost method investment, partially offset by higher net losses attributed to foreign exchange rate fluctuations
|
|
Interest Income
|
á
|
Increase due to higher overall investment balances and higher yields during the current fiscal period relative to the prior comparative period
|
|
|
Fiscal Quarter Ended
|
|
Fiscal Year-To-Date Ended
|
||
|
|
June 26,
2015 |
June 27,
2014 |
|
June 26,
2015 |
June 27,
2014 |
|
Provision for income taxes
|
$(11,522)
|
$(11,251)
|
|
$(45,254)
|
$(53,079)
|
|
Effective tax rate
|
24%
|
22%
|
|
25%
|
25%
|
|
Factor
|
Impact On Effective Tax Rate
|
|
|
U.S. Manufacturing Tax Incentives
|
á
|
Increase in the effective rate attributed to reduced benefits from U.S. manufacturing tax incentives
|
|
Factor
|
Impact On Effective Tax Rate
|
|
|
Federal R&D Credits
|
â
|
Increase in discrete benefits from federal R&D credits that were retroactively reinstated for the 2014 calendar year
|
|
U.S. Manufacturing Tax Incentives
|
á
|
Reduced benefits attributed to reduced benefits from U.S. manufacturing tax incentives
|
|
|
June 26,
2015 |
September 26,
2014 |
||||
|
|
(in thousands)
|
|||||
|
Cash and cash equivalents
|
$
|
470,868
|
|
$
|
568,472
|
|
|
Short-term investments
|
165,833
|
|
231,208
|
|
||
|
Long-term investments
|
373,498
|
|
296,335
|
|
||
|
Accounts receivable, net
|
103,921
|
|
86,168
|
|
||
|
Accounts payable and accrued liabilities
|
191,342
|
|
174,274
|
|
||
|
Working capital
(1)
|
686,171
|
|
816,481
|
|
||
|
(1)
|
Working capital consists of total current assets less total current liabilities.
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
June 26,
2015 |
June 27,
2014 |
||||
|
Net cash provided by operating activities
|
$
|
226,117
|
|
$
|
271,968
|
|
|
Factor
|
Impact On Cash Flows
|
|
|
Net Income
|
â
|
Increase in operating expenses including depreciation as total revenues remained relatively flat relative to the prior comparable period
|
|
Working capital
|
â
|
Net overall decrease attributed to an increase in accounts receivable resulting from timing differences, partially offset by an increase in accounts payable and accrued liabilities due to the timing of outbound payments made during the current period
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
June 26,
2015 |
June 27,
2014 |
||||
|
Net cash used in investing activities
|
$
|
(254,693
|
)
|
$
|
(111,327
|
)
|
|
Capital expenditures
|
(119,787
|
)
|
(37,122
|
)
|
||
|
Factor
|
Impact On Cash Flows
|
|
|
Business combinations
|
â
|
Cash outflows during fiscal 2015 relating to the acquisition of Doremi Labs
|
|
Proceeds from sales & maturities of investments
|
á
|
Higher cash inflows from sales & maturities of marketable securities
|
|
Capital expenditures
|
â
|
Increased investments in PP&E including improvements for our new worldwide headquarters at 1275 Market Street in San Francisco, CA
|
|
Purchase of investments
|
â
|
Higher cash outflows from purchases of marketable securities
|
|
|
Fiscal Year-To-Date Ended
|
|||||
|
|
June 26,
2015 |
June 27,
2014 |
||||
|
Net cash used in financing activities
|
$
|
(66,657
|
)
|
$
|
(24,175
|
)
|
|
Repurchase of common stock
|
(47,956
|
)
|
(40,958
|
)
|
||
|
Factor
|
Impact On Cash Flows
|
|
|
Dividend payments
|
â
|
Cash dividend payments made to common stockholders in the current fiscal period as no similar payments occurred during the prior comparative period
|
|
Share repurchases
|
â
|
Higher cash outflows for a higher volume of common stock repurchases
|
|
Partnership distribution
|
â
|
Distributions to our controlling interest for accumulated commercial property leasing fees in fiscal 2015 while no distributions were made in the prior comparative period
|
|
•
|
Australian Dollar
|
|
•
|
British Pound
|
|
•
|
Chinese Yuan
|
|
•
|
Euro
|
|
•
|
Indian Rupee
|
|
•
|
Japanese Yen
|
|
•
|
Korean Won
|
|
•
|
Polish Zloty
|
|
•
|
Russian Ruble
|
|
•
|
Swedish Krona
|
|
•
|
Purchasing trends away from traditional PCs and toward computing devices without optical disc drives, such as ultrabooks and tablets;
|
|
•
|
Because PC OEMs are required to pay us a higher per-unit royalty for Windows 8 and Windows 10 PCs that include optical disc playback functionality than Windows 8 or Windows 10 PCs that do not include such functionality, the continued decreasing inclusion of optical disc drives in Windows 8 or Windows 10 PCs will result in lower per-unit royalties;
|
|
•
|
PC software that includes our technologies on an unauthorized and infringing basis, for which we receive no royalty payments; and
|
|
•
|
Continued decreasing inclusion of independent software vendor media applications by PC OEMs.
|
|
•
|
Exhibitors may choose competing products with different features or lower prices; and
|
|
•
|
Pricing and other competitive pressures have caused us to implement pricing strategies which have adversely affected gross margins of our cinema products.
|
|
•
|
Timing of royalty reports from our licensees and meeting revenue recognition criteria;
|
|
•
|
Royalty reports including positive or negative corrective adjustments;
|
|
•
|
Retroactive royalties that cover extended periods of time; and
|
|
•
|
Timing of revenue recognition under licensing agreements and other contractual arrangements, including recognition of unusually large amounts of revenue in any given quarter because not all of our revenue recognition criteria were met in prior periods.
|
|
•
|
Rapid technological change;
|
|
•
|
New and improved technology and frequent product introductions;
|
|
•
|
Changing consumer and licensee demands;
|
|
•
|
Evolving industry standards; and
|
|
•
|
Technology and product obsolescence.
|
|
•
|
Possibility that innovations may not be protectable;
|
|
•
|
Failure to protect innovations that later turn out to be important;
|
|
•
|
Insufficient patent protection to prevent third parties from designing around our patent claims;
|
|
•
|
Our pending patent applications may not be approved; and
|
|
•
|
Possibility that an issued patent may later be found to be invalid or unenforceable.
|
|
•
|
Our ability to enforce our contractual and intellectual property rights, especially in countries that do not recognize and enforce intellectual property rights to the same extent as the U.S., Japan, Korea, and European countries do, which increases the risk of unauthorized use of our technologies;
|
|
•
|
Limited or no patent protection for our Dolby Digital technologies in countries such as China, Taiwan, and India, which may require us to obtain patent rights for new and existing technologies in order to grow or maintain our revenue; and
|
|
•
|
Because of limitations in the legal systems in many countries, our ability to obtain and enforce patents in many countries is uncertain, and we must strengthen and develop relationships with entertainment industry participants worldwide to increase our ability to enforce our intellectual property and contractual rights without relying solely on the legal systems in the countries in which we operate.
|
|
•
|
Content creators, such as film directors, studios, music producers and mobile and online content producers;
|
|
•
|
Content distributors, such as film exhibitors, broadcasters, operators, and OTT video service providers and video game publishers; and
|
|
•
|
Device manufacturers.
|
|
•
|
Diversion of management time and focus from operating our business to acquisition integration challenges;
|
|
•
|
Cultural and logistical challenges associated with integrating employees from acquired businesses into our organization;
|
|
•
|
Retaining employees, suppliers and customers from businesses we acquire;
|
|
•
|
The need to implement or improve internal controls, procedures, and policies appropriate for a public company at businesses that prior to the acquisition may have lacked effective controls, procedures, and policies;
|
|
•
|
Possible write-offs or impairment charges resulting from acquisitions;
|
|
•
|
Unanticipated or unknown liabilities relating to acquired businesses; and
|
|
•
|
The need to integrate acquired businesses’ accounting, management information, manufacturing, human resources, and other administrative systems to permit effective management.
|
|
•
|
U.S. and foreign government trade restrictions, including those which may impose restrictions on importation of programming, technology, or components to or from the U.S.;
|
|
•
|
Compliance with applicable international laws and regulations, including antitrust laws, that may differ or conflict with laws in other countries where we conduct business, or are otherwise not harmonized with one another;
|
|
•
|
Foreign government taxes, regulations, and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the U.S., and other laws limiting our ability to repatriate funds to the U.S.;
|
|
•
|
Changes in diplomatic and trade relationships;
|
|
•
|
Difficulty in establishing, staffing, and managing foreign operations;
|
|
•
|
Adverse fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake;
|
|
•
|
Political or social instability, natural disasters, war or events of terrorism; and
|
|
•
|
The strength of international economies.
|
|
•
|
Earnings being lower than anticipated in countries that have lower tax rates and higher than anticipated in countries that have higher tax rates;
|
|
•
|
Changes in the valuation of our deferred tax assets and liabilities;
|
|
•
|
Expiration of or lapses in the R&D tax credit laws;
|
|
•
|
Fluctuations in tax exempt interest income;
|
|
•
|
Transfer pricing adjustments;
|
|
•
|
Tax effects of nondeductible compensation;
|
|
•
|
Tax costs related to intercompany realignments;
|
|
•
|
Any obligations or decisions to repatriate earnings from abroad earlier than anticipated;
|
|
•
|
Changes in accounting principles; or
|
|
•
|
Changes in tax laws and regulations in the countries in which we operate, including possible U.S. changes to the taxation of earnings of our foreign subsidiaries. For example, the OECD, an international association of 34 countries including the United States, is contemplating revisions to certain corporate tax, transfer pricing, and tax treaty provisions. When the OECD finalizes these revisions, they will be adopted in various forms by many countries in which we operate. These revisions could increase our income taxes and adversely affect our provision for income taxes.
|
|
Repurchase Activity
|
Total Shares Repurchased
|
Average Price
Paid Per Share (1) |
Total Shares Purchased As Part Of Publicly Announced Programs
|
Remaining Authorized Share Repurchases
(2)
|
|
March 28, 2015 - April 24, 2015
|
—
|
$—
|
—
|
$227.7 million
|
|
April 25, 2015 - May 22, 2015
|
153,000
|
40.06
|
153,000
|
$221.6 million
|
|
May 23, 2015 - June 26, 2015
|
237,000
|
39.90
|
237,000
|
$212.1 million
|
|
Total
|
390,000
|
|
390,000
|
|
|
(1)
|
Average price paid per share excludes commission costs.
|
|
(2)
|
Amounts represent the approximate dollar value of the maximum remaining number of shares that may yet be purchased under the stock repurchase program, and excludes commission costs.
|
|
Exhibit
Number
|
|
Description
|
|
Incorporated By Reference Herein
|
|
|
||||
|
|
Form
|
|
File Number
|
|
Date
|
|
Filed Herewith
|
|||
|
31.1
|
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
32.1
‡
|
|
Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
|
|
|
|
|
|
|
|
X
|
|
101.INS
‡
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
X
|
|
101.SCH
‡
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
X
|
|
101.CAL
‡
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
101.DEF
‡
|
|
XBRL Extension Definition
|
|
|
|
|
|
|
|
X
|
|
101.LAB
‡
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
101.PRE
‡
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
X
|
|
DOLBY LABORATORIES, INC.
|
|
|
By:
|
/
S
/ LEWIS CHEW
|
|
|
Lewis Chew
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|